内科病房危重症事件的时间聚集性
该回顾性队列研究纳入加拿大多伦多5家医院2010年4月1日至2017年10月31日收治于普通内科病房的118529例住院患者,分析同一病房6小时区间内危重症事件(院内死亡或ICU转运)与后续患者发生同一复合结局的关联。暴露于前6小时内1起事件(AOR 1.39;95%CI 1.30-1.48)和>1起事件(AOR 1.49;95%CI 1.33-1.68)均与复合结局风险升高相关;后续ICU转运风险升高(1起事件AOR 1.67;95%CI 1.54-1.81;>1起事件AOR 2.05;95%CI 1.79-2.36),单纯死亡无显著关联。同院不同病房之间无显著关联。提示ICU转运在内科病房存在时间聚集,可能涉及识别增强、抢先转运、资源转移或床位容量波动。
要点
- 同一病房前6小时内发生1起危重症事件,后续患者复合结局风险升高(AOR 1.39;95%CI 1.30-1.48)。
- 同一病房前6小时内发生>1起危重症事件,后续患者复合结局风险升高(AOR 1.49;95%CI 1.33-1.68)。
- 后续ICU转运风险随暴露事件数增加:1起事件AOR 1.67(95%CI 1.54-1.81),>1起事件AOR 2.05(95%CI 1.79-2.36)。
- 单纯院内死亡与暴露无显著关联:1起事件AOR 1.08(95%CI 0.97-1.19),>1起事件AOR 0.88(95%CI 0.71-1.09)。
- 同院不同病房的危重症事件之间无显著关联。
适用人群与场景
- 2010年4月1日至2017年10月31日收治于加拿大多伦多5家医院普通内科病房的住院患者,共118529例住院(中位年龄72岁,IQR 56-83岁;50.7%男性)。
研究设计与关键结果
- 研究类型:回顾性队列研究,5家医院,118529例住院,普通内科病房。
- 主要结局为院内死亡或ICU转运复合终点,共8785例住院(7.4%)发生。
- 采用离散时间生存分析,调整患者与情境因素;以同院不同可比病房作为阴性对照。
- 暴露于前6小时内1起危重症事件:复合结局AOR 1.39(95%CI 1.30-1.48);>1起事件:AOR 1.49(95%CI 1.33-1.68),均以无暴露为参照。
- 后续ICU转运:1起事件AOR 1.67(95%CI 1.54-1.81);>1起事件AOR 2.05(95%CI 1.79-2.36)。
- 单纯死亡:1起事件AOR 1.08(95%CI 0.97-1.19);>1起事件AOR 0.88(95%CI 0.71-1.09)。
- 同院不同病房的危重症事件之间无显著关联。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,患者在同一病房另一患者发生危重症事件后的数小时内更可能被转入ICU。
- 作者认为,该现象可能有多重解释,包括对危重症识别增强、抢先ICU转运、资源向首起事件转移或病房/ICU容量波动。
- 作者认为,更好地理解内科病房ICU转运的聚集性可能改善患者安全。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Recognizing and preventing patient deterioration is important for hospital safety.
OBJECTIVE: To investigate whether critical illness events (in-hospital death or intensive care unit [ICU] transfer) are associated with greater risk of subsequent critical illness events for other patients on the same medical ward.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study in 5 hospitals in Toronto, Canada, including 118 529 hospitalizations. Patients were admitted to general internal medicine wards between April 1, 2010, and October 31, 2017. Data were analyzed between January 1, 2020, and April 10, 2023.
EXPOSURES: Critical illness events (in-hospital death or ICU transfer).
MAIN OUTCOMES AND MEASURES: The primary outcome was the composite of in-hospital death or ICU transfer. The association between critical illness events on the same ward across 6-hour intervals was studied using discrete-time survival analysis, adjusting for patient and situational factors. The association between critical illness events on different comparable wards in the same hospital was measured as a negative control.
RESULTS: The cohort included 118 529 hospitalizations (median age, 72 years [IQR, 56-83 years]; 50.7% male). Death or ICU transfer occurred in 8785 hospitalizations (7.4%). Patients were more likely to experience the primary outcome after exposure to 1 prior event (adjusted odds ratio [AOR], 1.39; 95% CI, 1.30-1.48) and more than 1 prior event (AOR, 1.49; 95% CI, 1.33-1.68) in the prior 6-hour interval compared with no exposure. The exposure was associated with increased odds of subsequent ICU transfer (1 event: AOR, 1.67; 95% CI, 1.54-1.81; >1 event: AOR, 2.05; 95% CI, 1.79-2.36) but not death alone (1 event: AOR, 1.08; 95% CI, 0.97-1.19; >1 event: AOR, 0.88; 95% CI, 0.71-1.09). There was no significant association between critical illness events on different wards within the same hospital.
CONCLUSIONS AND RELEVANCE: Findings of this cohort study suggest that patients are more likely to be transferred to the ICU in the hours after another patient's critical illness event on the same ward. This phenomenon could have several explanations, including increased recognition of critical illness and preemptive ICU transfers, resource diversion to the first event, or fluctuations in ward or ICU capacity. Patient safety may be improved by better understanding the clustering of ICU transfers on medical wards.
参考来源
- Doshi S, Shin S, Lapointe-Shaw L, et al. Temporal Clustering of Critical Illness Events on Medical Wards. JAMA Intern Med. 2023. PMID: 37428478. doi:10.1001/jamainternmed.2023.2629
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。